The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3-((2-(2-Methoxyphenoxy)ethyl)amino)propoxy)benzene-1,2-diol ID: ALA4459541
PubChem CID: 155527582
Max Phase: Preclinical
Molecular Formula: C18H23NO5
Molecular Weight: 333.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccccc1OCCNCCCOc1ccc(O)c(O)c1
Standard InChI: InChI=1S/C18H23NO5/c1-22-17-5-2-3-6-18(17)24-12-10-19-9-4-11-23-14-7-8-15(20)16(21)13-14/h2-3,5-8,13,19-21H,4,9-12H2,1H3
Standard InChI Key: ISBAPZLLRFJIGB-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
14.9174 -28.8227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6254 -29.2317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3351 -28.8223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3322 -27.9996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0384 -27.5884 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7477 -27.9943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4538 -27.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1631 -27.9889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8692 -27.5777 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5785 -27.9836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9185 -28.0032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6218 -27.5958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2108 -27.5946 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2093 -29.2308 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2846 -27.5723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9939 -27.9783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.7000 -27.5670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4076 -27.9755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1133 -27.5649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1107 -26.7468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3964 -26.3411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6937 -26.7540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9828 -26.3509 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9765 -25.5337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 1 2 0
1 2 1 0
2 3 2 0
3 4 1 0
4 12 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
11 12 1 0
11 13 1 0
1 14 1 0
10 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
22 23 1 0
23 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 333.38Molecular Weight (Monoisotopic): 333.1576AlogP: 2.54#Rotatable Bonds: 10Polar Surface Area: 80.18Molecular Species: BASEHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.67CX Basic pKa: 9.06CX LogP: 1.80CX LogD: 0.52Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.46Np Likeness Score: -0.09
References 1. Stanek M, Picard LP, Schmidt MF, Kaindl JM, Hübner H, Bouvier M, Weikert D, Gmeiner P.. (2019) Hybridization of β-Adrenergic Agonists and Antagonists Confers G Protein Bias., 62 (10): [PMID:31042379 ] [10.1021/acs.jmedchem.9b00349 ]